スポンサーリンク
Division Of Hematology Keio University School Of Medicine | 論文
- Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma : Prognostic factors and unique toxicity profile
- Thalidomide-Induced Severe Neutropenia during Treatment of Multiple Myeloma
- Recurrence of Autoimmune Disease after Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
- Thalidomide for the Treatment of Refractory Multiple Myeloma : Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
- Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity
- Current and future perspectives on the TARGET system : the registration system for Glivec^【○!R】 established by the JSH
- Cantharidin induces apoptosis of human multiple myeloma cells via inhibition of the JAK/STAT pathway
- Bone Marrow Angiogenesis and Anti-Angiogenic Therapy in Multiple Myeloma
- Application of Molecular and Clinical Biologies in a Novel Acute Promyelocytic Leukemia Model : From Cell to Murine System
- A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathway
- Bone Marrow Angiogenesis and Anti-Angiogenic Therapy in Multiple Myeloma